Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated February 9th, 2022

Multiple Myeloma: The Future of CAR T-Cell Therapy & Other Treatments


Patient Pathfinder

We're here to help. Have you had any treatment for myeloma yet?

You might want to check out some top experts outlining the initial treatment for myeloma.

Got it. Are you looking for maintenance treatment?

You might want to check out some top experts outlining maintenence treatment for myeloma.

Ok. Has your Myeloma come back? Here are some useful resources:

If you’ve had at least four treatments that have not worked or stopped working you might be a candidate for a treatment called CAR T Therapy.

Here’s some important information to consider::

CAR-T Therapy for Multiple Myeloma

Learn More
10 Years Cancer-Free: Emily Whitehead, Now 17, the First Pediatric Cancer Patient to Receive CAR T-Cell Therapy, Celebrates Major Milestone
'Miracle' Journey of Girl, 5, Successfully Treated with Car T-Cell Therapy to Premiere at Prestigious Tribeca Film Festival!
Understanding PI3K Inhibitors: How Can This Type of Targeted Therapy Treat CLL?
How is Melanoma Treated After Surgery?
Obinutuzumab for CLL
New Therapy Provides Hope for More Patients With Large B-Cell Lymphoma

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.